Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets

摘要

BackgroundSignificant gaps remain regarding the pathomechanisms underlying the autoimmune response in vitiligo (VL), where the loss of self-tolerance leads to the targeted killing of melanocytes. Specifically, there is incomplete information regarding alterations in the systemic environment that are relevant to the disease state.